Ask AI
Adjuvant CDK4/6 Inhibitors for HR+/HER2- EBC

CE / CME

Maximizing Patient Benefit With Adjuvant CDK4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Pharmacists: 0.25 contact hour (0.025 CEUs)

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Released: February 27, 2026

Expiration: August 26, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How confident are you in your ability to apply shared decision-making and communication strategies to support patient adherence/persistence on adjuvant CDK4/6 inhibitor treatment?